2022 Will Bring New Questions For Sarepta; Jefferies Raises Price Target From $7 To $50
September 20, 2016 at 10:57 AM EDT
Jefferies raised its rating on Sarepta Therapeutics Inc (NASDAQ: SRPT) as the din dies down on the euphoria generated by the company ...